Broader Considerations of Higher Doses of Donepezil in the Treatment of Mild, Moderate, and Severe Alzheimer's Disease

Donepezil, a highly selective acetylcholinesterase inhibitor (AChEI), is approved as a symptomatic treatment mild, moderate, and severe Alzheimer's disease (AD). Donepezil exerts its treatment effect through multiple mechanisms of action including nicotinic receptor stimulation, mitigation of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Berk, Camryn, Sabbagh, Marwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235571/
https://www.ncbi.nlm.nih.gov/pubmed/22191061
http://dx.doi.org/10.1155/2012/707468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235571/
https://www.ncbi.nlm.nih.gov/pubmed/22191061
http://dx.doi.org/10.1155/2012/707468

Ejemplares similares